Emerging insights into the complex link between atopic dermatitis and ADHD in children

A new review explores the nuanced relationship between atopic dermatitis and attention-deficit/hyperactivity disorder, emphasising the roles of chronic itch, sleep disruption, and stress, while cautioning against assuming direct causation.

Children with atopic dermatitis may be more likely to develop attention-deficit/hyperactivity disorder, but researchers say the link is not straightforward and may reflect the burden of chronic itch, poor sleep and ongoing stress rather than a direct cause. A narrative review published online in Pediatric Investigation argues that the two conditions often travel together in children and adolescents, yet genetic evidence has not supported a simple one-way relationship between them.

The review says the strongest associations appear in children with early-onset, persistent or more severe eczema. Earlier meta-analyses have found that youngsters with atopic dermatitis have higher odds of ADHD, and one global review reported ADHD in about 9% of children with eczema. Other studies have suggested the risk rises as skin disease worsens, with sleep disruption emerging as a major factor. In severe cases, the combination of intense itching and marked sleep loss may be especially disruptive to attention and behaviour.

Researchers involved in the review propose an “inflammation–itch–neurobehavioural axis” to explain the overlap. The theory is that type 2 inflammation, chronic pruritus, fragmented sleep and stress may together affect attention, impulse control and executive function. But the authors also caution that some children with eczema may show ADHD-like symptoms without meeting the criteria for a formal diagnosis. Inattention, restlessness and irritability can improve if the skin disease and sleep problems are brought under control.

That distinction matters for treatment. The review recommends that clinicians actively screen for ADHD symptoms in children with moderate to severe or early-onset atopic dermatitis, especially when sleep is poor. It also advises using standard symptom checklists and focusing first on reducing inflammation and itch. If ADHD is independently diagnosed and affects day-to-day life, treatment should follow usual ADHD guidance. The authors note that stimulant medicines such as methylphenidate can worsen insomnia, while atomoxetine has been linked with rash and itch in some patients.

The overall picture, the review concludes, is one of frequent co-existence rather than proven causation. A separate population study in the UK found no significant association after accounting for other factors, and Mendelian randomisation analyses have not shown that genetic liability to either condition directly causes the other. The authors say better prospective studies are needed to determine whether earlier control of eczema, sleep disturbance and stress can improve both skin and behavioural outcomes.